Status:
COMPLETED
Surgical Excision and Intralesional Steroid Injection for Prevention of Post Caesarean Keloid Recurrence
Lead Sponsor:
Kasr El Aini Hospital
Conditions:
Keloid
Eligibility:
FEMALE
20-45 years
Phase:
PHASE4
Brief Summary
Two groups of patients (73 patients each) undergoing routine caesarean section has recurrent keloid at site of surgical scar. One group will undergo surgical excision of keloid. The other group will h...
Detailed Description
One hundred forty six patients that are admitted at Kasr Al Aini teaching university hospital for caesarean section, will be enrolled in this randomized clinical trial after approval by the local ethi...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Documented keloids of pfannenstiel incision or midline subumbilical incision of one to five years duration.
- Previous treatment of keloid and recurrence.
- Patient complaint of cosmetic disfiguring, pain or pruritis at site of scar.
- Exclusion criteria:
- Scar \<1 years' duration
- Scar extending beyond the limits of the original lesion
- postburn keloids
- Diabetes Mellitus, anaemia (haemoglobin level \<10mg/dL), malignancy, malnutrition.
- local inflammation at site of scar
- Allergy to dexamethasone.
- Immunocompromized patients or patients on chronic steroid treatment.
Exclusion
Key Trial Info
Start Date :
August 10 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 24 2018
Estimated Enrollment :
146 Patients enrolled
Trial Details
Trial ID
NCT03239964
Start Date
August 10 2016
End Date
January 24 2018
Last Update
November 5 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
KasralainiH
Cairo, Egypt, 11956